{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:01:00Z","timestamp":1773864060034,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1016\/s1056-8727(02)00277-5","type":"journal-article","created":{"date-parts":[[2003,10,24]],"date-time":"2003-10-24T21:00:59Z","timestamp":1067029259000},"page":"314-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"title":["Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2"],"prefix":"10.1016","volume":"17","author":[{"given":"Carlos","family":"Abraira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Duckworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeline","family":"McCarren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Emanuele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Arca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenic","family":"Reda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S1056-8727(02)00277-5_BIB2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2337\/diacare.21.4.669","article-title":"A critical issue: intensive insulin treatment and macrovascular disease","volume":"21","author":"Abraira","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB1","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2337\/diacare.18.8.1113","article-title":"Results of the feasibility trial","volume":"18","author":"Abraira","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archinte.1997.00440230053007","article-title":"Cardiovascular events and correlates in the VA Feasibility Trial (VACSDM)","volume":"157","author":"Abraira","year":"1997","journal-title":"Archives of Internal Medicine"},{"issue":"Suppl. 1","key":"10.1016\/S1056-8727(02)00277-5_BIB4","first-page":"5","article-title":"Consensus statement on guidelines for glycemic control","volume":"8","year":"2002","journal-title":"Endocrine Practice"},{"issue":"Suppl. 1","key":"10.1016\/S1056-8727(02)00277-5_BIB5","first-page":"S33","article-title":"Clinical practice recommendations 2002","volume":"25","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB6","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.2337\/diacare.20.10.1620","article-title":"Does hyperglycemia really cause coronary artery heart disease?","volume":"20","author":"Barrett-Connor","year":"1997","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/S1056-8727(02)00277-5_BIB7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2165\/00002512-200017060-00004","article-title":"Beneficial and detrimental effects of intensive glycemic control, with emphasis on type 2 diabetes mellitus","volume":"17","author":"Camacho","year":"2000","journal-title":"Drugs & Aging"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB8","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/ajcp\/109.3.274","article-title":"Evaluation and interference study of hemoglobin A1c measured by turbidometric inhibition immunoassay","volume":"109","author":"Chang","year":"1998","journal-title":"American Journal of Clinical Pathology"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB10","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1182\/blood.V71.1.220.220","article-title":"Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay","volume":"71","author":"DeClerk","year":"1988","journal-title":"Blood"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB11","unstructured":"Department of Veterans Affairs, Office of Quality and Performance. Management of diabetes mellitus in primary care [Link: Annotations]. Available at: http:\/\/www.oqp.med.va.gov\/cpg\/DM\/dm_cpg\/content\/ModG\/modG_fr.htm. Accessed October 2002."},{"key":"10.1016\/S1056-8727(02)00277-5_BIB12","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB13","doi-asserted-by":"crossref","first-page":"942","DOI":"10.2337\/diacare.24.5.942","article-title":"The Department of Veterans Affairs Diabetes Trial","volume":"24","author":"Duckworth","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB14","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.2337\/diacare.21.10.1596","article-title":"The Veterans Affairs Implantable Insulin Group study: effect on cardiovascular risk factors","volume":"21","author":"Duckworth","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2337\/diacare.20.5.735","article-title":"Model of complications of NIDDM II: analysis of the health benefits and cost effectiveness of treating NIDDM","volume":"20","author":"Eastman","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB17","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1001\/jama.1992.03490100090033","article-title":"Aspirin effects on mortality and morbidity in patients with diabetes mellitus: early treatment diabetic retinopathy study report 14","volume":"268","year":"1992","journal-title":"JAMA, Journal of the American Medical Association"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB18","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/jama.1993.03500100088034","article-title":"How effective are treatments for diabetic retinopathy?","volume":"269","author":"Ferris","year":"1993","journal-title":"JAMA, Journal of the American Medical Association"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB19","series-title":"Diabetes in America","first-page":"133","article-title":"Mortality in non-insulin-dependent diabetes","author":"Geiss","year":"1995"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0031-9384(95)00085-W","article-title":"Hypoglycemia-induced cognitive dysfunction in diabetes mellitus: effect of hypoglycemia unawareness","volume":"58","author":"Gold","year":"1995","journal-title":"Physiology & Behavior"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/(SICI)1096-9136(199702)14:2<111::AID-DIA309>3.0.CO;2-S","article-title":"Hypoglycaemia and non-cognitive aspects of psychological function in insulin-dependent (type 1) diabetes mellitus (IDDM)","volume":"14","author":"Gold","year":"1997","journal-title":"Diabetic Medicine"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB22","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/0002-8703(90)90026-T","article-title":"Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience","volume":"120","author":"Kannel","year":"1990","journal-title":"American Heart Journal"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB23","series-title":"Diabetes in America","first-page":"293","article-title":"Vision disorders in diabetes","author":"Klein","year":"1995"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB24","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2337\/diabetes.48.5.937","article-title":"Hyperglycemia and cardiovascular disease in type 2 diabetes","volume":"48","author":"Laakso","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB25","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.2337\/diacare.23.10.1478","article-title":"The effect of intensive glycemic control on microalbuminuria in type 2 diabetes mellitus","volume":"23","author":"Levin","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB26","series-title":"Neuropsychological assessment","first-page":"357","article-title":"Orientation and attention","author":"Lezak","year":"1995"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0002-9343(96)00383-X","article-title":"Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): the NIDDM patient outcomes research team","volume":"102","author":"Meigs","year":"1997","journal-title":"American Journal of Medicine"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB28","unstructured":"National Committee for Quality Assurance & American Diabetes Association. Diabetes Physician Recognition Program. Available at: http:\/\/www.ncqa.org\/dprp. Accessed October 2002."},{"key":"10.1016\/S1056-8727(02)00277-5_BIB29","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2337\/diacare.20.4.614","article-title":"Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)","volume":"20","author":"Pyorala","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB30","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"Cholesterol and recurrent events trial investigators: the effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels","volume":"335","author":"Sacks","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB31","first-page":"B21","article-title":"Long term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients","volume":"23","author":"Shichiri","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ, British Medical Journal"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB33","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/clinchem\/13.11.1026","article-title":"Fibrinogen assay","volume":"13","author":"Swaim","year":"1967","journal-title":"Clinical Chemistry"},{"issue":"1, Pt. 2","key":"10.1016\/S1056-8727(02)00277-5_BIB34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7326\/0003-4819-124-1_Part_2-199601011-00011","article-title":"The effect of improved metabolic control on complications of NIDDM: UKPDS 17","volume":"124","author":"Turner","year":"1996","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB35","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risks of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB36","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","year":"1998","journal-title":"BMJ, British Medical Journal"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB37","doi-asserted-by":"crossref","first-page":"788","DOI":"10.7326\/0003-4819-127-9-199711010-00003","article-title":"Estimated benefits of glycemic control in microvascular complications in type 2 diabetes","volume":"127","author":"Vijan","year":"1997","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000205234","article-title":"Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens","volume":"17","author":"von Clauss","year":"1957","journal-title":"Acta Haematologica"},{"key":"10.1016\/S1056-8727(02)00277-5_BIB38","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2337\/diacare.23.7.919","article-title":"Performance status of health care facilities changes with risk adjustment of HbA1c","volume":"23","author":"Zhang","year":"2000","journal-title":"Diabetes Care"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872702002775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872702002775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:06:37Z","timestamp":1761005197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872702002775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["S1056872702002775"],"URL":"https:\/\/doi.org\/10.1016\/s1056-8727(02)00277-5","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2003,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1056-8727(02)00277-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}